Bloom Energy is laying the groundwork for its ambitious 2026 growth targets through a significant capacity expansion and a record...

For shareholders of Gene Biotherapeutics, the wait for substantive news continues. The company, formerly known as Taxus Cardium Pharmaceuticals Group,...

The biopharmaceutical giant AbbVie finds itself navigating a complex landscape where promising research initiatives are counterbalanced by resurgent legal challenges....

Significant portfolio adjustments are underway among major market participants holding shares of Astera Labs. The AI infrastructure sector is witnessing...

Recent clinical trial data from Ocular Therapeutix has generated significant attention within ophthalmology investment circles. The company's key drug candidate,...

The renewable fuels industry is undergoing a significant structural shift. This transformation is creating a new landscape for producers like...

Neonode is undergoing a fundamental strategic reinvention. The company's management is steering a radical transformation toward becoming a specialized software...

Oracle is undertaking a significant modernization of its core software platforms to capture opportunities in artificial intelligence. The recent launch...

The American food conglomerate General Mills is navigating a cautious consumer environment by implementing strategic price reductions. While this move...

As AGNC Investment Corp. approaches a pivotal date on its corporate calendar, shareholders are preparing to weigh in on the...